Viemed Healthcare, Inc. Common Shares (VMD) Stock Price
VMDStock
$9.48+38.39%52W
Market Cap$361.08M
P/E24.18x
PEG Ratio2.42
Div yield—
Beta1.04
VMD Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-12.27%
Price vs S&P 500 (4W)8.44%
PEG Ratio2.42
VGM Score49.86
P/E Ratio (Annual)24.18x
VMD Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.10 | $0.07 | -30.00%(-$0.03) | |
| Q1 2026 | $0.09 | $0.06 | -33.33%(-$0.03) | |
| Q4 2025 | $0.13 | $0.14 | +12.00%(+$0.02) | |
| Q3 2025 | $0.09 | $0.09 | +0.00%(+$0.00) | |
| Q2 2025 | $0.09 | $0.08 | -11.11%(-$0.01) |
VMD Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.00
Industry Peers — Health Services(17)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
VMDViemed Healthcare, Inc. Common Shares | B | C | C | 24.2x | 25.2% | 7.5% | 10.3% | $9.48 |
| DVADaVita Inc. | B | C | B | 16.0x | 6.5% | 15.1% | 181.2% | $187.31 |
| FMSFresenius Medical Care AG | A | D | C | 10.7x | -0.5% | 9.4% | 7.2% | $22.17 |
| SHCSotera Health Company Common Stock | D | B | C | 65.5x | 8.2% | 32.6% | 26.8% | $17.89 |
| PGNYProgyny, Inc. Common Stock | C | B | C | 35.2x | 5.5% | 8.6% | 16.0% | $26.86 |
| AGLagilon health, inc. | B | B | B | — | 0.3% | -5.2% | -110.3% | $85.12 |
| MCTACharming Medical Limited Class A Ordinary Shares | F | F | A | 371.6x | — | 15.4% | — | $29.36 |
| PARKPark Dental Partners, Inc. Common Stock | B | F | C | 17.9x | — | -2.8% | -18.3% | $18.95 |
| CCELCryo-Cell International Inc. | C | D | B | 69.5x | -2.0% | 0.6% | 38.2% | $4.42 |
| MGRXMangoceuticals, Inc. Common Stock | D | F | F | — | -38.9% | -4761.2% | -106.1% | $0.29 |
| BRTXBioRestorative Therapies, Inc. Common Stock (NV) | — | D | F | — | -8.5% | -3975.0% | -423.8% | $1.54 |
About Viemed Healthcare, Inc. Common Shares
Viemed Healthcare supplies medical equipment and home therapy services for patients with respiratory disease, sleep apnea, and related conditions. The company generates revenue primarily through equipment rental and sales, with additional services including disease management, in-home sleep testing, and healthcare staffing.